![](/img/cover-not-exists.png)
Phase I trial of 1-(2′-deoxy-2′-fluoro-1-beta-D-arabinofuranosyl)-5-methyluracil (FMAU) terminated by severe neurologic toxicity
James L. Abbruzzese, Susan Schmidt, Martin N. Raber, Joel K. Levy, Augustin M. Castellanos, Sewa S. Legha, Irwin H. KrakoffVolume:
7
Language:
english
Pages:
7
DOI:
10.1007/bf00170857
Date:
July, 1989
File:
PDF, 560 KB
english, 1989